MétaCan
Menu
Back to cohort
Record W2800860839 · doi:10.1016/j.ebiom.2018.04.018

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents

2018· article· en· W2800860839 on OpenAlexfundno aff
Matthieu Duchmann, Fevzi Yalniz, Alessandro Sanna, David A. Sallman, Catherine C. Coombs, Aline Renneville, Olivier Kosmider, Thorsten Braun, Uwe Platzbecker, Lise Willems, Lionel Adès, Michaëla Fontenay, Raajit K. Rampal, Eric Padron, Nathalie Droin, Claude Preudhomme, Valeria Santini, Mrinal M. Patnaik, Pierre Fenaux, Éric Solary, Raphaël Itzykson

Bibliographic record

VenueEBioMedicine · 2018
Typearticle
Languageen
FieldMedicine
TopicAcute Myeloid Leukemia Research
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesJanssen BiotechAbbVieNational Cancer InstituteMinistère des Affaires Sociales et de la SantéChildhood Cancer CanadaLigue Contre le CancerAssociation Laurette FugainPharmacyclicsCelgeneJanssen PharmaceuticalsGilead SciencesNational Center for Research ResourcesNovartisAmgen
KeywordsChronic myelomonocytic leukemiaMedicineInternal medicineAzacitidineHazard ratioDecitabineOncologyMultivariate analysisProportional hazards modelOdds ratioHypomethylating agentCohortGastroenterologyConfidence intervalGeneDNA methylationMyelodysplastic syndromesBiologyGeneticsBone marrow

Abstract

fetched live from OpenAlex

Somatic mutations contribute to the heterogeneous prognosis of chronic myelomonocytic leukemia (CMML).Hypomethylating agents (HMAs) are active in CMML, but analyses of small series failed to identify mutations predicting response or survival.We analyzed a retrospective multi-center cohort of 174 CMML patients treated with a median of 7 cycles of azacitidine (n = 68) or decitabine (n = 106).Sequencing data before treatment initiation were available for all patients, from Sanger (n = 68) or next generation (n = 106) sequencing.Overall response rate (ORR) was 52%, including complete response (CR) in 28 patients (17%).In multivariate analysis, ASXL1 mutations predicted a lower ORR (Odds Ratio [OR] = 0.85, p = 0.037), whereas TET2 mut /ASXL1 wt genotype predicted a higher CR rate (OR = 1.18, p = 0.011) independently of clinical parameters.With a median follow-up of 36.7 months, overall survival (OS) was 23.0 months.In multivariate analysis, RUNX1 mut (Hazard Ratio [HR] = 2.00, p = .011),CBL mut (HR = 1.90, p = 0.03) genotypes and higher WBC (log 10 (WBC) HR = 2.30, p = .005)independently predicted worse OS while the TET2 mut /ASXL1 wt predicted better OS (HR = 0.60, p = 0.05).CMMLspecific scores CPSS and GFM had limited predictive power.Our results stress the need for robust biomarkers of HMA activity in CMML and for novel treatment strategies in patients with myeloproliferative features and RUNX1 mutations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.297
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations82
Published2018
Admission routes1
Has abstractyes

Explore more

Same venueEBioMedicineSame topicAcute Myeloid Leukemia ResearchFrench-language works237,207